TelyRx Holdings Inc. (TELY : TSX)
Common Stock
$2.45
CAD
-0.30 (-10.91%)
Last updated: 2026-06-22
TELY
TelyRx Holdings Inc.
Performance
1 Day
-10.91%
1 Week
+6.52%
1 Month
-18.33%
YTD
-30.00%
Key Statistics
Market Cap
$73.09M
52W High
$4.25
52W Low
$2.00
P/E Ratio
-
50 Day MA
$2.85
200 Day MA
$2.88
Beta
-
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/22/2026 | $2.63 | $2.63 | $2.20 | $2.45 | $2.45 | 13,800 |
| 6/19/2026 | $2.75 | $2.75 | $2.75 | $2.75 | $2.75 | 0 |
| 6/18/2026 | $2.75 | $3.00 | $2.75 | $2.75 | $2.75 | 12,900 |
| 6/17/2026 | $2.70 | $3.00 | $2.50 | $2.75 | $2.75 | 17,883 |
| 6/16/2026 | $2.53 | $2.70 | $2.53 | $2.70 | $2.70 | 8,400 |
| 6/15/2026 | $2.30 | $2.30 | $2.30 | $2.30 | $2.30 | 100 |
| 6/12/2026 | $2.35 | $2.35 | $2.30 | $2.30 | $2.30 | 14,000 |
| 6/11/2026 | $2.30 | $2.30 | $2.30 | $2.30 | $2.30 | 6,900 |
| 6/9/2026 | $2.59 | $2.75 | $2.45 | $2.45 | $2.45 | 17,900 |
| 6/8/2026 | $2.45 | $2.60 | $2.35 | $2.40 | $2.40 | 12,893 |
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 144.9% over the next 12 months.
Consensus
No RatingAvg. Target
C$6.00
+144.9% Upside
Current Price
C$2.45
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
107.6%
Annualized
90-Day Vol
100.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.05
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.31 | C$1.59 โ C$3.35 |
| 60 trading days | C$2.18 | C$1.29 โ C$3.68 |
| 90 trading days | C$2.05 | C$1.08 โ C$3.90 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About TelyRx Holdings Inc.
TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company which develops and operates a digital pharmacy platform. Its platform connects patients nationwide with physicians for access to everyday prescriptions. The company also operates pharmacies which ship the medicine to the patient's door with next-day delivery. It caters to doctors, veterinarians, practice groups, and other licensed prescribers. The company is based in Clearwater, Florida.
Financials
- Revenue (TTM)
- $55.39M
- EBITDA
- $-7.74M
- Profit Margin
- -18.17%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -0.57
- Book Value
- 0.75
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About TELY
Articles Featuring TELY.TO
Latest articles and analysis covering TELY.TO
Why TelyRx Holdings Inc. stock is plummeting today
TelyRx Holdings Inc. experienced a significant drop in stock price today, raising questions about its financial viability despite recent revenue growth.

Why TelyRx Holdings Inc. stock is skyrocketing today
TelyRx Holdings Inc. experienced a significant stock price increase of 17.39% in the last trading session, closing at CA$2.70. This upward movement is a positive sign for investors, especially in light of the company's recent financial performance.

Why TelyRx Holdings Inc. stock is skyrocketing today
TelyRx Holdings Inc. has experienced a remarkable 10% increase in its stock price today, fueled by impressive revenue growth reported in its recent financial results. The company's strong performance in the healthcare sector positions it as a compelling investment opportunity.

Why TelyRx Holdings Inc. stock is plummeting today
TelyRx Holdings Inc. (TELY.TO) faced a significant setback in its stock performance, closing down 6.12% at CA$2.30. This decline follows a period of revenue growth but also highlights ongoing financial challenges, including a widening net loss.

Why TelyRx Holdings Inc. stock is plummeting today
TelyRx Holdings Inc. experienced a sharp decline in its stock price today, falling by 6.12% to CA$2.30. This drop comes despite recent reports of revenue growth, raising questions about the company's financial health and future prospects.

Why TelyRx Holdings Inc. stock is skyrocketing today
TelyRx Holdings Inc. shares jumped nearly 8% today, driven by anticipation surrounding its participation in an upcoming investor conference.

Why TelyRx Holdings Inc. stock is skyrocketing today
TelyRx Holdings Inc. has surged by 13.64% in a single trading day, driven by excitement surrounding its upcoming presentation at a virtual investor conference. This event could be pivotal for the company's future growth and investor engagement.

Why TelyRx Holdings Inc. stock is plummeting today
TelyRx Holdings Inc. saw a dramatic 17.55% drop in stock price today, closing at CA$2.02. Investors are left to ponder the implications of this decline as the company prepares for an important investor conference.
